A patient presents with acute COPD exacerbation and respiratory acidosis. What is the initial management?

• A. Inhaled bronchodilators (nebulized albuterol with ipratropium), systemic corticosteroids, and antibiotics if signs of infection
• B. Oxygen therapy only
• C. Immediate intubation
• D. Antibiotics only

Answer: (A)

Managing an acute COPD exacerbation with respiratory acidosis focuses on rapidly relieving airway obstruction, reducing inflammation, and supporting ventilation while looking for triggers like infection. Starting with inhaled bronchodilators helps to open the airways quickly, improving airflow and gas exchange. Nebulized albuterol with ipratropium targets both beta-agonist–induced smooth muscle relaxation and muscarinic constriction, providing robust bronchodilation. Systemic corticosteroids shorten the exacerbation by dampening airway inflammation, which also improves ventilation and reduces the need for further escalation. Antibiotics are added when there are signs of infection (such as purulent sputum, fever, or leukocytosis), since infection can drive the illness and worsen gas exchange.

Oxygen supplementation should be used to achieve adequate oxygen levels, but it must be carefully titrated in COPD to avoid depressing the respiratory drive in patients who already retain CO2. If ventilation worsens despite these measures, noninvasive ventilation or, if necessary, intubation may be required, but these are not the initial steps for most patients.

Thus, the combination of bronchodilators, systemic steroids, and antibiotics when infection is suspected represents the best initial management for this scenario.